The Technical AnalystExchange: TAI Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
LIWANLI Innovation Co., Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.94% TWD21.05
America/New_York / 3 mai 2024 @ 01:16
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 697.70 mill |
| EPS: | 0.0600 |
| P/E: | 350.83 |
| Earnings Date: | May 30, 2024 |
| SharesOutstanding: | 80.65 mill |
| Avg Daily Volume: | 0.0299 mill |
| RATING 2024-05-03 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 18.92x |
| Company: PE 350.83 | sector: PE 18.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 29.25x |
| Company: PE 350.83 | industry: PE 11.99 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD-7.28 (-134.58%) TWD-28.33 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
TWD 20.64 - 21.47 ( +/- 1.97%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD21.05 (-0.94% ) |
| Volume | 0.0510 mill |
| Avg. Vol. | 0.0299 mill |
| % of Avg. Vol | 170.44 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 3054.TW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
3054.TW
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin Q10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat's milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.